Does DUPILUMAB Cause Injection site pain? 27,799 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27,799 reports of Injection site pain have been filed in association with DUPILUMAB (Dupixent). This represents 7.3% of all adverse event reports for DUPILUMAB.
27,799
Reports of Injection site pain with DUPILUMAB
7.3%
of all DUPILUMAB reports
15
Deaths
542
Hospitalizations
How Dangerous Is Injection site pain From DUPILUMAB?
Of the 27,799 reports, 15 (0.1%) resulted in death, 542 (1.9%) required hospitalization, and 5 (0.0%) were considered life-threatening.
Is Injection site pain Listed in the Official Label?
Yes, Injection site pain is listed as a known adverse reaction in the official FDA drug label for DUPILUMAB.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
Arthralgia (15,176)
What Other Drugs Cause Injection site pain?
ADALIMUMAB (28,679)
ETANERCEPT (24,717)
TIRZEPATIDE (10,989)
EVOLOCUMAB (9,988)
DULAGLUTIDE (9,474)
GALCANEZUMAB-GNLM (6,622)
HUMIRA (6,005)
GLATIRAMER (5,003)
LEUPROLIDE (4,678)
EXENATIDE (4,577)
Which DUPILUMAB Alternatives Have Lower Injection site pain Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE